GradedCallsGradedCalls Analysts
Loading the ledger…
Call grade
Wolfe Research · Aug 13, 2026 · ABBV · Healthcare
Desk rating Peer Perform → Outperform
No prior target
Adjusted close
Buy, Hold, or Sell bucket used by the score.
Upgraded to Outperform from Peer Perform; target $300.
Note restates the rating and target from the source. It is not a quotation of a research report.
The large number is the GC score for that window, on the GC Scale from 1 to 10. GC 1 is a poor track record. GC 10 is an excellent one. The same card shows the full score out of 100. 70+ is STRONG, 40–69 PROVISIONAL, under 40 WEAK; a graded 0 is EXIT LIQUIDITY. A graded score of exactly 0 is an empty glass at 0% and reads EXIT LIQUIDITY. The badge is a dash, not GC 1. An open horizon stays ungraded and reads Not graded yet. A hit is a full direction match. Near-misses earn 35 of 70 direction points and do not count in the hit rate.
2W
2 weeks after the call
8/10GC 1 → GC 10
Score 70/100
GC 8–10. At or above 70 is STRONG on the GC Scale.
Direction for grading is Buy. That bucket expects the shares to rise at least 1% over 2 weeks.
30D
30 days after the call
8/10GC 1 → GC 10
Score 70/100
GC 8–10. At or above 70 is STRONG on the GC Scale.
Direction for grading is Buy. That bucket expects the shares to rise at least 2% over 30 days.
60D
60 days after the call
10/10GC 1 → GC 10
Score 93.2/100
GC 8–10. At or above 70 is STRONG on the GC Scale.
Direction for grading is Buy. That bucket expects the shares to rise at least 4% over 60 days.
90D
90 days after the call
This window has no recorded price yet, so the call stays ungraded. Open windows are left out of hit rate and score.
Direction for grading is Buy. That bucket expects the shares to rise at least 5% over 90 days.
1Y
1 year after the call
This window has no recorded price yet, so the call stays ungraded. Open windows are left out of hit rate and score.
Direction for grading is Buy. That bucket expects the shares to rise at least 8% over 1 year.